PMID: 7535827Apr 1, 1995Paper

Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships

The Journal of Infectious Diseases
D L ThomasT C Quinn

Abstract

The prevalence of antibodies to hepatitis C virus (anti-HCV), the behavioral and laboratory-derived risk factors for anti-HCV, and the quantity and homology of HCV RNA were assessed among 1039 non-injection drug-using sexually transmitted disease (STD) patients representing 309 sex partnerships. Thirty-seven (7%) of 555 males and 19 (4%) of 484 females had anti-HCV. In logistic regression analyses, factors associated with anti-HCV included age (P < .001), greater numbers of lifetime sex partners (P = .023), human immunodeficiency virus infection (P < .001), Trichomonas infection (P < .001), cigarette smoking (P < .001), and male homosexual exposure (P = .012). Among couples, females whose sex partners were anti-HCV positive were 3.7 times more likely to have anti-HCV than females whose sex partners were anti-HCV negative (P = .039). The proportion of RNA homology between anti-HCV positive females and their male partners (94%) was higher than among randomly selected patients (82%). Sexual transmission of HCV may contribute to the high prevalence of anti-HCV reported in urban settings.

Citations

Mar 3, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S A VillanoD L Thomas
Sep 18, 2001·Current Infectious Disease Reports·Mark S. Sulkowski
Mar 29, 2001·Irish Journal of Medical Science·C M HealyK M Butler
Aug 11, 2005·Current HIV/AIDS Reports·Mark S Sulkowski
Feb 1, 2000·The American Journal of Medicine·I Williams
Sep 1, 2000·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M P LimaM D Rocha
Aug 14, 2003·The Journal of Pediatrics·Samer S El-KamaryAnne K Duggan
Mar 25, 1999·The Journal of Infection·M ManaviH Hofmann
Jan 6, 1999·Journal of Hepatology·U Spengler, J K Rockstroh
Jan 6, 2000·Journal of Hepatology·M J Alter
Jan 6, 2000·Journal of Hepatology·R Wejstål
Jan 6, 2000·Journal of Hepatology·J P Zarski, V Leroy
Aug 12, 2000·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·D Lavanchy, P Gavinio
Jul 10, 2013·Nature Medicine·David L Thomas
Mar 6, 2002·Journal of Viral Hepatitis·M I Memon, M A Memon
Jan 1, 1996·Vox Sanguinis·L Sánchez-BeizaV Soriano
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David L Thomas
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Norah A Terrault
Aug 19, 1999·The New England Journal of Medicine·M J AlterH S Margolis
Apr 20, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M S SulkowskiD L Thomas
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L Y HwangM Holleman
Oct 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mahmood ManaviKlaus Czerwenka
May 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ellen M TedaldiUNKNOWN Terry Beirn Community Programs for Clinical Research on AIDS
Aug 9, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Melissa A MarxDavid D Celentano
Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M AugenbraunN Terrault
Dec 19, 2002·Journal of Clinical Gastroenterology·Tommy YenAijaz Ahmed
Nov 29, 2001·Sexually Transmitted Diseases·P FilippiniF Piccinino
Jan 7, 2003·Sexually Transmitted Diseases·Barbara RomanowskiJayne Fenton
Apr 28, 2004·Southern Medical Journal·Brian L Pearlman
Jul 1, 1997·Journal of Gastroenterology and Hepatology·D B Smith, P Simmonds
Jul 9, 2004·HIV Medicine·J GhosnC Katlama
Jul 15, 2003·Clinical Microbiology Reviews·David K Henderson
May 31, 2001·Microbiology and Molecular Biology Reviews : MMBR·N Dejucq, B Jégou
May 25, 1996·BMJ : British Medical Journal·M C Allison, P R Mills

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.